<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04969783</url>
  </required_header>
  <id_info>
    <org_study_id>P01CA217806-S2</org_study_id>
    <secondary_id>P01CA217806</secondary_id>
    <nct_id>NCT04969783</nct_id>
  </id_info>
  <brief_title>Telehealth-Filter Ventilation ( COMET2P1 )</brief_title>
  <official_title>Telehealth Study Assessing the Removal of Filter Ventilation on Smoking Behavior and Biomarkers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masonic Cancer Center, University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Masonic Cancer Center, University of Minnesota</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goals of this project are to determine the effects of varying degrees of cigarette filter&#xD;
      ventilation on biomarkers of toxicant exposure and smoking behavior and on subjective&#xD;
      responses to the cigarette.&#xD;
&#xD;
      The primary aim of this study is to examine the effects of unventilated vs ventilated filter&#xD;
      cigarettes on urinary biomarkers of toxicant exposure and smoking behavior (e.g., cigarettes&#xD;
      per day, intensity of smoking). The secondary objectives are 1) to examine the effects of&#xD;
      cigarette filter ventilation on subjective measures such as cigarette dependence and&#xD;
      responses to study cigarettes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This randomized controlled multi-site study will assess the effect of cigarettes with&#xD;
      unventilated vs. ventilated filters on smoking behavior and biomarkers of tobacco toxicant&#xD;
      exposure. The study, using telehealth and brief visits, will also examine the feasibility of&#xD;
      remote collection of multiple biological samples.&#xD;
&#xD;
      Subjects (N=184; N=92 in each group) will be randomly assigned to: 1) Ventilated cigarettes;&#xD;
      or 2) Unventilated cigarettes. Smokers will undergo an in person screening and then a 9 week&#xD;
      experimental trial with one week of baseline; 1 week of usual brand cigarettes; 2 weeks of&#xD;
      ventilated study cigarettes and 6 weeks on either the ventilated or unventilated study&#xD;
      cigarettes.&#xD;
&#xD;
      Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per day will be&#xD;
      collected remotely. Biological samples collected at home will be dropped off at the clinic&#xD;
      where the study cigarettes will be dispensed.&#xD;
&#xD;
      Biomarker samples (total nicotine equivalents, tobacco specific nitrosamines, volatile&#xD;
      organic compound and inflammation markers) will be collected remotely and dropped off at the&#xD;
      clinic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2022</start_date>
  <completion_date type="Anticipated">September 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Phase III randomized, single blind, multi-center study assessing the impact of filter ventilation</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>Single blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Total NNAL: 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol</measure>
    <time_frame>6 weeks</time_frame>
    <description>Absolute change from baseline level of total NNAL (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) at the week 6 visit</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in cigarettes per day (CPD)</measure>
    <time_frame>7 days prior to baseline visit and 7 days prior to week 6 visit</time_frame>
    <description>The absolute change from baseline for the mean CPD based on the mean CPD for 7 days prior to baseline visit 1 and 7 days prior to week 6 visit using ITR (Interactive Text Response), daily diary reviewed data.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Tobacco Use</condition>
  <arm_group>
    <arm_group_label>Ventilated Cigarette Filter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Filters with approximately 24-32% filter ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unventilated Cigarette Filter</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Filters with approximately 0-5.0% filter ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ventilated Cigarette Filter</intervention_name>
    <description>Ventilated Cigarette Filter</description>
    <arm_group_label>Ventilated Cigarette Filter</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Unventilated Cigarette Filter</intervention_name>
    <description>Unventilated Cigarette Filter</description>
    <arm_group_label>Unventilated Cigarette Filter</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  At least 21 years of age&#xD;
&#xD;
          -  Biochemically confirmed regular cigarette smoker&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unstable health&#xD;
&#xD;
          -  Unstable medications&#xD;
&#xD;
          -  Pregnant or nursing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dorothy K Hatsukami, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Masonic Cancer Center, University of Minnesota</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joni Jensen, MPH</last_name>
    <phone>612-624-5178</phone>
    <email>jense010@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lori Strayer, MPH</last_name>
    <phone>612-626-5189</phone>
    <email>strayer@umn.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Minnesota Tobacco Research Program</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55414</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Joni A Jensen</last_name>
      <phone>612-624-5178</phone>
      <email>jense010@umn.edu</email>
    </contact>
    <investigator>
      <last_name>Dorothy K Hatsukami, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio State University Comprehensive Cancer Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Sarah Reisinger, MPH, MCHES</last_name>
      <phone>614-366-4542</phone>
      <email>Sarah.Reisinger@osumc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Peter Shields, MD</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 6, 2021</study_first_submitted>
  <study_first_submitted_qc>July 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>July 9, 2021</last_update_submitted>
  <last_update_submitted_qc>July 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cigarette smoking</keyword>
  <keyword>filter ventilation</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Intend to share findings from this research through publications and presentations. Institutions and individuals wishing to access any resources or data must contact the Principal Investigator (Hatsukami). Data will be available in two formats. One will be a summary of the data, with graphs and tables, posted as pdf files and as raw individual-level data for analysis. Data generated by this grant will be made to outside investigators, according to NIH Guidance. When data are shared, there will be no limits placed on how the data will be used. Users will agree, however, that the recipient must not transfer the data to other users and that the data are only to be used for research purposes. A record of transfer of data and a copy of the dataset that was distributed will be kept by University of Minnesota.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Data will not be available until primary and secondary papers are accepted for publication</ipd_time_frame>
    <ipd_access_criteria>Persons requesting data must do so in writing, identifying their affiliation and how the data will be used. Upon review, access will be determined.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

